Myomo (MYO) Insider William Febbo Buys 78,704 Shares
William Febbo recently bought 78,704 shares of Myomo, Inc., trading at $1.14.
Reviewed by automated data checks against the source filing. How we make and check alerts
William Febbo bought 78,704 shares of Myomo, Inc. ($MYO) on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $MYO is down 4.6% after 1 week, down 1.9% after 1 month and up 11.1% to date (from the $1.08 close on Jun 25, 2026).
MYO
Myomo, Inc.
Key Points
- William Febbo purchased 78,704 shares of Myomo, Inc. on June 25, 2026, with the stock trading at $1.14 on Saturday.
- Myomo, Inc. has a market cap of approximately $39.8 million, with a 52-week high of $2.38 and a low of $0.60.
- Rosalind Advisors increased its holdings in Myomo, Inc. by 7,500 shares, while Vanguard Capital Management opened a new position with 1,144,324 shares.
Get $MYO trade alerts by text
We text you when insiders, Congress or big funds trade $MYO. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Myomo, Inc. alert may contain errors. Disclosures
William Febbo, a notable insider, bought 78,704 shares of Myomo, Inc. (NYSE American: MYO) on June 25, 2026. The transaction did not specify a price, but as of Saturday, the stock was trading at $1.14.
Insider Buying and Selling at Myomo, Inc.
Several insiders, including William Febbo, made purchases of 78,704 shares each on June 25, 2026. These transactions were not part of any pre-arranged trading plans.
Other Institutional Activity in Myomo, Inc.
Rosalind Advisors, Inc. added 7,500 shares to its holdings, bringing its total to 3,847,272 shares valued at approximately $2.6 million, marking a 0.2% increase. Meanwhile, BlackRock, Inc. trimmed its position by 24,389 shares, reducing its total to 1,688,390 shares worth about $1.14 million, a 1.4% decrease. Vanguard Capital Management LLC opened a new position with 1,144,324 shares valued at $773,563. Geode Capital Management, LLC increased its stake by 121,830 shares, ending with 858,799 shares valued at around $580,274, reflecting a 16.5% increase.
Myomo, Inc. Stock Down 28.2%
Shares of NYSE American: MYO traded at $1.14 on Saturday. Myomo, Inc. has a market capitalization of about $39.8 million. The company is not currently profitable, which means it has no meaningful P/E ratio. With a beta of 1.46, the stock has experienced a 52-week low of $0.60 and a high of $2.38. Its 50-day moving average is $1.02, and the 200-day moving average is $0.92. The company maintains a current ratio of 2.73 and a quick ratio of 2.19, though it carries a high debt-to-equity ratio of 210.65.
Analysts Set New Price Targets
On June 8, 2026, Ascendiant Capital maintained a 'buy' rating for Myomo, Inc., setting a price target of $10. The stock has a consensus target price of $4.42 among five analysts, with the highest target at $10 and the lowest at $1.10.
About Myomo, Inc.
Myomo, Inc., based in Burlington, Massachusetts, designs and manufactures wearable medical robotics. Its main product, MyoPro, is a myoelectric-controlled brace that supports the arms of individuals with neuromuscular conditions. The company's offerings aim to improve the daily lives of patients with conditions such as stroke and spinal cord injury. Myomo operates in the United States and internationally, selling through various channels including orthotics providers and the veteran's administration.
Bottom Line
Insider activity at Myomo, Inc. suggests interest from key individuals, though such transactions don't necessarily predict future stock performance. The company, known for its innovative medical devices, continues to attract institutional interest. Myomo's stock remains volatile, reflecting its developmental stage and financial metrics.
Related Filing Alerts
Source: William Febbo's Form 4 filing on $MYO (Jun 25, 2026). Find the original filing: MYO Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts